Cargando…

From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease

Pompe disease (PD) is caused by mutations in the GAA gene, which encodes the lysosomal enzyme acid alpha-glucosidase, causing lysosomal glycogen accumulation, mainly in muscular tissue. Autophagic buildup is considered the main factor affecting skeletal muscle, although other processes are also invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Porras, Valentina, Guevara-Morales, Johana Maria, Echeverri-Peña, Olga Yaneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419125/ https://www.ncbi.nlm.nih.gov/pubmed/37569856 http://dx.doi.org/10.3390/ijms241512481

Ejemplares similares

Molecular Diagnosis of Pompe Disease in the Genomic Era: Correlation with Acid Alpha-Glucosidase Activity in Dried Blood Spots
por: Thuriot, Fanny, et al.
Publicado: (2021)

Metabolic impact of infant formulas in young infants. An outlook from the urine metabolome
por: Calvo Barbosa, Angie Marcela, et al.
Publicado: (2022)

Identification of Seven Novel Mutations in the Acid Alpha-glucosidase Gene in Five Chinese Patients with Late-onset Pompe Disease
por: Liu, Hua-Xu, et al.
Publicado: (2018)

Clinical manifestations and acid alpha-glucosidase mutation characterisation of a cohort of patients with late-onset Pompe disease in eastern China
por: Zhao, Hui-Hui, et al.
Publicado: (2021)

Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
por: Roig-Zamboni, Véronique, et al.
Publicado: (2017)

Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts
por: Cardone, Monica, et al.
Publicado: (2008)

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase
por: Cagin, Umut, et al.
Publicado: (2020)

Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease
por: Gal, Aniko, et al.
Publicado: (2021)

Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease
por: Aung-Htut, May Thandar, et al.
Publicado: (2020)

Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease
por: van Kooten, Harmke A., et al.
Publicado: (2022)

Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects
por: Colella, Pasqualina, et al.
Publicado: (2020)

A Nonsense Mutation in the Acid α-Glucosidase Gene Causes Pompe Disease in Finnish and Swedish Lapphunds
por: Seppälä, Eija H., et al.
Publicado: (2013)

Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
por: Maga, John A., et al.
Publicado: (2013)

Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease
por: Liang, Qiushi, et al.
Publicado: (2022)

AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice
por: Meena, Naresh K., et al.
Publicado: (2023)

The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease
por: Khanna, Richie, et al.
Publicado: (2014)

Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state
por: Matsuoka, Takashi, et al.
Publicado: (2016)

Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α
por: Kishnani, Priya, et al.
Publicado: (2017)

Peptide modulators of alpha-glucosidase
por: Roskar, Irena, et al.
Publicado: (2015)

The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease
por: Khanna, Richie, et al.
Publicado: (2012)

Atg5(flox)-Derived Autophagy-Deficient Model of Pompe Disease: Does It Tell the Whole Story?
por: Lim, Jeong-A, et al.
Publicado: (2017)

Three years experience with dried blood spot α-glucosidase screening for Pompe disease in British Columbia, Canada
por: Horvath, Gabriella, et al.
Publicado: (2013)

(1)H-Nuclear Magnetic Resonance Analysis of Urine as Diagnostic Tool for Organic Acidemias and Aminoacidopathies
por: Pulido, Ninna, et al.
Publicado: (2021)

Miconia sp. Increases mRNA Levels of PPAR Gamma and Inhibits Alpha Amylase and Alpha Glucosidase
por: Ortíz-Martinez, David Mizael, et al.
Publicado: (2016)

Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase Rescues Both Muscle and CNS Defects in Murine Pompe Disease
por: Lim, Jeong-A, et al.
Publicado: (2019)

Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from Nuxia oppositifolia
por: Alqahtani, Ali S., et al.
Publicado: (2019)

1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease
por: Kok, Ken, et al.
Publicado: (2022)

Pompes turbomoleculaires
por: Versolatto, B
Publicado: (1982)

Production of Human Acid-Alpha Glucosidase With a Paucimannose Structure by Glycoengineered Arabidopsis Cell Culture
por: Sariyatun, Ratna, et al.
Publicado: (2021)

Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
por: van de Laar, Floris Alexander
Publicado: (2008)

Inhibitory Properties of Aqueous Ethanol Extracts of Propolis on Alpha-Glucosidase
por: Zhang, Hongcheng, et al.
Publicado: (2015)

Alpha Glucosidase Inhibitory Activities of Plants with Focus on Common Vegetables
por: Assefa, Samuel Tilahun, et al.
Publicado: (2019)

Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
por: Devaraj, Surabhi, et al.
Publicado: (2021)

Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
por: Kim, Hee-Woong, et al.
Publicado: (2023)

Specific saposin C deficiency: CNS impairment and acid β-glucosidase effects in the mouse
por: Sun, Ying, et al.
Publicado: (2010)

GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies
por: Leal, Andrés Felipe, et al.
Publicado: (2020)

Characteristics of Pompe disease in China: a report from the Pompe registry
por: Zhao, Yuying, et al.
Publicado: (2019)

Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase
por: Selvan, Nithya, et al.
Publicado: (2021)

Suppression of lysosomal acid alpha‐glucosidase impacts the modulation of transcription factor EB translocation in pancreatic cancer
por: Hamura, Ryoga, et al.
Publicado: (2021)

Cloning and Molecular Characterization of an Alpha-Glucosidase (MalH) from the Halophilic Archaeon Haloquadratum walsbyi
por: Cuebas-Irizarry, Mara F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8elc9bgt43odnf3qpl4cqilom6